ES445981A1 - Procedimiento para la preparacion de un compuesto intermedioen la sintesis de 9 alfa-halogeno-16 beta-metil-prednisolo- na. - Google Patents

Procedimiento para la preparacion de un compuesto intermedioen la sintesis de 9 alfa-halogeno-16 beta-metil-prednisolo- na.

Info

Publication number
ES445981A1
ES445981A1 ES445981A ES445981A ES445981A1 ES 445981 A1 ES445981 A1 ES 445981A1 ES 445981 A ES445981 A ES 445981A ES 445981 A ES445981 A ES 445981A ES 445981 A1 ES445981 A1 ES 445981A1
Authority
ES
Spain
Prior art keywords
methyl
synthesis
prednisolone
halogen
translation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES445981A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aldo Union Calzada Y Cia S R C
Original Assignee
Aldo Union Calzada Y Cia S R C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aldo Union Calzada Y Cia S R C filed Critical Aldo Union Calzada Y Cia S R C
Priority to ES445981A priority Critical patent/ES445981A1/es
Publication of ES445981A1 publication Critical patent/ES445981A1/es
Expired legal-status Critical Current

Links

Landscapes

  • Steroid Compounds (AREA)
ES445981A 1976-03-11 1976-03-11 Procedimiento para la preparacion de un compuesto intermedioen la sintesis de 9 alfa-halogeno-16 beta-metil-prednisolo- na. Expired ES445981A1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES445981A ES445981A1 (es) 1976-03-11 1976-03-11 Procedimiento para la preparacion de un compuesto intermedioen la sintesis de 9 alfa-halogeno-16 beta-metil-prednisolo- na.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES445981A ES445981A1 (es) 1976-03-11 1976-03-11 Procedimiento para la preparacion de un compuesto intermedioen la sintesis de 9 alfa-halogeno-16 beta-metil-prednisolo- na.

Publications (1)

Publication Number Publication Date
ES445981A1 true ES445981A1 (es) 1977-06-01

Family

ID=8471128

Family Applications (1)

Application Number Title Priority Date Filing Date
ES445981A Expired ES445981A1 (es) 1976-03-11 1976-03-11 Procedimiento para la preparacion de un compuesto intermedioen la sintesis de 9 alfa-halogeno-16 beta-metil-prednisolo- na.

Country Status (1)

Country Link
ES (1) ES445981A1 (es)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9198921B2 (en) 2010-04-05 2015-12-01 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US10857161B2 (en) 2008-05-28 2020-12-08 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kB for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10857161B2 (en) 2008-05-28 2020-12-08 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kB for treatment of disease
US11833159B2 (en) 2008-05-28 2023-12-05 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kB for treatment of disease
US9198921B2 (en) 2010-04-05 2015-12-01 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions
US11471471B2 (en) 2019-03-07 2022-10-18 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions
US12201639B2 (en) 2019-03-07 2025-01-21 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Similar Documents

Publication Publication Date Title
BG37075A3 (bg) Метод за получаване на производни на пролина
BG32851A3 (bg) Метод за получаване на 3,4,5,6-тетрахидро-2н- -1-бензоксецини
ES456541A1 (es) Procedimiento para la preparacion de acidos n-fosfonometilen-monoaminoalcanmonofosfonicos y -polifosfonicos yno acidos n-fosfonometilen-diaminoalcanpolifosfonicos.
BG28849A3 (bg) Метод за получаване на гамапирони
BG32856A3 (bg) Метод за получаване на 1-оксадетилацефалоспорий
ES445981A1 (es) Procedimiento para la preparacion de un compuesto intermedioen la sintesis de 9 alfa-halogeno-16 beta-metil-prednisolo- na.
ES432334A1 (es) Procedimiento de obtencion de derivados 1-amido alquil-4- sulfonil-piperazina.
BG28064A3 (en) Method of obtaining of 2,6-methane-2h-1-benzoxozines
BG28056A3 (bg) Метод за получаване на 5-амино-1,2,3-тиадиазол
BG28054A3 (bg) Метод за получаване на 2-(4-ароил-пиперазин-1-ил)-4-амино-6,7- диметоксихиназолини
BG31073A3 (bg) Метод за получаване на 1,5-заместени-2-пиролидони
BG33288A3 (en) Method for obtaining of 6- methyl- 8 (substituated)- methylergolin
BG33436A3 (en) Method for obtaining of 4- dezacetyl- vinblastine- 3- spiro- 5"- oxazolidin- 2", 4"- dion
NL7702546A (nl) Werkwijze ter bereiding van waterstof.
ES462843A1 (es) Un procedimiento para la preparacion de compuestos imidazo (1,5-a) (1,4)diacepinicos.
BG28062A3 (en) Method of obtaining of 6a,10a, cishexahydrodibenzopyranones
BG29871A3 (bg) Метод за получаване на 6,7-диметокси-1,2,3,4-тетрахидро-1- изохинолилацетамиди
ES456144A1 (es) Procediento para la preparacion de fenilguanidinas sustitui-das.
BG28063A3 (en) Method of obtaining of 6a,10a- cishexahydrodibenzopyranones
ES438725A1 (es) Un procedimiento de preparacion de derivados sustituidos del acido prostanoico.
JPS5229348A (en) Umbrella
ES457089A1 (es) Procedimiento para la preparacion de nuevos colorantes basi-cos de antraquinona.
JPS522504A (en) Tone arm
JPS5272531A (en) Method for degital indication
ES475967A3 (es) Procedimiento para la obtencion de derivados fenoxi-carboxi-licos.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19910204